Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00607_DB08815_nanopub.RABgOFzdcPqYyEiMvCIF6-V5fS_IoOtLkPAcF9-CQB2RA#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00607_DB08815 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00607_DB08815 label "DDI between Nafcillin and Lurasidone - Concomitant therapy will decrease levels of lurasidone via effects on CYP 3A4. Concomitant therapy is contraindicated. [drugbank_resource:DB00607_DB08815]" assertion.
- drugbank_resource:DB00607_DB08815 identifier "drugbank_resource:DB00607_DB08815" assertion.
- drugbank_resource:DB00607_DB08815 title "DDI between Nafcillin and Lurasidone - Concomitant therapy will decrease levels of lurasidone via effects on CYP 3A4. Concomitant therapy is contraindicated." assertion.
- drugbank:DB08815 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00607_DB08815 assertion.
- drugbank:DB00607 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00607_DB08815 assertion.